Functional and Structural Characterization of the Arylamine N-Acetyltransferase from the Opportunistic Pathogen Nocardia farcinica

Journal of Molecular Biology

Volumn 383, Issue 3, 2008, Pages 549-560

  Martins, Marta ^a   Pluvinage, Benjamin ^a   de la Sierra Gallay, Inès Li ^b   Barbault, Florent ^c   Dairou, Julien ^a   Dupret, Jean Marie ^a   Rodrigues Lima, Fernando ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

antibiotics; arylamine N acetyltransferase; mycobacteria; Nocardia farcinica; structure

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ISONIAZID; SULFAMETHOXAZOLE;

ACETYLATION; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME PURIFICATION; ENZYME STRUCTURE; NOCARDIA FARCINICA; NOCARDIOSIS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN FUNCTION; SEQUENCE ANALYSIS;

CORYNEBACTERINEAE; EUKARYOTA; MYCOBACTERIUM TUBERCULOSIS; NOCARDIA; NOCARDIA FARCINICA; PROKARYOTA;

EID: 52949145608     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.08.035     Document Type: Article

References (53)

1. Dupret J.M., and Rodrigues-Lima F. Structure and regulation of the drug-metabolizing enzymes arylamine N-acetyltransferases. Curr. Med. Chem. 12 (2005) 311-318
2. Sim E., Westwood I., and Fullam E. Arylamine N-acetyltransferases. Expert Opin. Drug Metab. Toxicol. 3 (2007) 169-184
3. Riddle B., and Jencks W.P. Acetyl-coenzyme A: arylamine N-acetyltransferase. Role of the acetyl-enzyme intermediate and the effects of substituents on the rate. J. Biol. Chem. 246 (1971) 3250-3258
4. Dupret J.M., and Grant D.M. Site-directed mutagenesis of recombinant human arylamine N-acetyltransferase expressed in Escherichia coli. Evidence for direct involvement of Cys68 in the catalytic mechanism of polymorphic human NAT2. J. Biol. Chem. 267 (1992) 7381-7385
5. Evans D.A.P., Manley K.A., and McKusick V.A. Genetic control of isoniazid metabolism in man. Br. Med. J. 2 (1960) 485-491
6. Grant D.M., Blum M., Beer M., and Meyer U.A. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol. Pharmacol. 39 (1991) 184-191
7. Rodrigues-Lima F., and Dupret J.M. In silico sequence analysis of arylamine N-acetyltransferases: evidence for an absence of lateral gene transfer from bacteria to vertebrates and first description of paralogs in bacteria. Biochem. Biophys. Res. Commun. 293 (2002) 783-792
8. Sandy J., Mushtaq A., Holton S.J., Schartau P., Noble M.E., and Sim E. Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines. Biochem. J. 390 (2005) 115-123
9. Sinclair J.C., Sandy J., Delgoda R., Sim E., and Noble M.E. Structure of arylamine N-acetyltransferase reveals a catalytic triad. Nat. Struct. Biol. 7 (2000) 560-564
10. Sandy J., Mushtaq A., Kawamura A., Sinclair J., Noble M., and Sim E. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis-an enzyme which inactivates the anti-tubercular drug, isoniazid. J. Mol. Biol. 318 (2002) 1071-1083
11. Westwood I.M., Holton S.J., Rodrigues-Lima F., Dupret J.M., Bhakta S., Noble M.E.M., and Sim E. Expression, purification, characterisation and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase. Biochem. J. 385 (2005) 605-612
12. Holton S.J., Dairou J., Sandy J., Rodrigues-Lima F., Dupret J.M., Noble M.E.M., and Sim E. Structure of Mesorhizobium loti arylamine N-acetyltransferase 1. Acta Crystallogr., Sect. F. 61 (2005) 14-16
13. Fullam E., Westwood I.M., Anderton M.C., Lowe E.D., Sim E., and Noble M.E. Divergence of cofactor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N-acetyltransferase. J. Mol. Biol. 375 (2008) 178-191
14. Zhang N., Liu L., Liu F., Wagner C.R., Hanna P.E., and Walters K.J. NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity. J. Mol. Biol. 363 (2006) 188-200
15. Wu H., Dombrovsky L., Tempel W., Martin F., Loppnau P., Goodfellow G.H., et al. Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases. J. Biol. Chem. 282 (2007) 30189-30197
16. Goodfellow G.H., Dupret J.M., and Grant D.M. Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2. Biochem. J. 348 (2000) 159-166
17. Liu F., Zhang N., Zhou X., Hanna P.E., Wagner C.R., Koepp D.M., and Walters K.J. Arylamine N-acetyltransferase aggregation and constitutive ubiquitylation. J. Mol. Biol. 361 (2006) 482-492
18. Walraven J.M., Trent J.O., and Hein D.W. Structure-function analyses of single nucleotide polymorphisms in human N-acetyltransferase 1. Drug Metab. Rev. 40 (2008) 169-184
19. Boukouvala S., and Fakis G. Arylamine N-acetyltransferases: what we learn from genes and genomes. Drug Metab. Rev. 37 (2005) 511-564
20. Deloménie C., Fouix S., Longuemaux S., Brahimi N., Bizet C., Picard B., et al. Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: evidence for highly selective acetylation of 5-aminosalicylic acid. J. Bacteriol. 183 (2001) 3417-3427
21. Rodrigues-Lima F., Dairou J., Diaz C.L., Rubio M.C., Sim E., Spaink H.P., and Dupret J.M. Cloning, functional expression and characterization of Mesorhizobium loti arylamine N-acetyltransferases: rhizobial symbiosis supplies leguminous plants with the xenobiotic N-acetylation pathway. Mol. Microbiol. 60 (2006) 505-512
22. Pluvinage B., Dairou J., Possot O.M., Martins M., Fouet A., Dupret J.M., and Rodrigues-Lima F. Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance. Biochemistry 46 (2007) 7069-7078
23. Payton M., Auty R., Delgoda R., Everett M., and Sim E. Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance. J. Bacteriol. 181 (1999) 1343-1347
24. Bhakta S., Besra G.S., Upton A.M., Parish T., Sholto-Douglas-Vernon C., Gibson K.J., et al. Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target. J. Exp. Med. 199 (2004) 1191-1199
25. Madikane V.E., Bhakta S., Russell A.J., Campbell W.E., Claridge T.D., Elisha B.G., et al. Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris. Bioorg. Med. Chem. 15 (2007) 3579-3586
26. Corti M.E., and Villafane-Fioti M.F. Nocardiosis: a review. Int. J. Infect. Dis. 7 (2003) 243-250
27. Ishikawa J., Yamashita A., Mikami Y., Hoshino Y., Kurita H., Hotta K., et al. The complete genomic sequence of Nocardia farcinica IFM 10152. Proc. Natl Acad. Sci. USA 101 (2004) 14925-14930
28. Koenig S., Mehlich A.M., Ackermann D., Hamid M.E., Saeed N.S., Mukhtar M., and El Hassan M. Homologous housekeeping proteins in Nocardia-the NoDaMS proteomic database. Front. Biosci. 13 (2008) 842-855
29. Brown-Elliott B.A., Brown J.M., Conville P.S., and Wallace Jr. R.J. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin. Microbiol. Rev. 19 (2006) 259-282
30. Anderton M.C., Bhakta S., Besra G.S., Jeavons P., Eltis L.D., and Sim E. Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG. Mol. Microbiol. 59 (2006) 181-192
31. Higgins D.G., Thompson J.D., and Gibson T.J. Using CLUSTAL for multiple sequence alignments. Methods Enzymol. 266 (1996) 383-402
32. Gouet P., Robert X., and Courcelle E. ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins. Nucleic Acids Res. 31 (2003) 3320-3323
33. Payton M., Mushtaq A., Yu T.W., Wu L.J., Sinclair J., and Sim E. Eubacterial arylamine N-acetyltransferases-identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues. Microbiology 147 (2001) 1137-1147
34. Payton M., Gifford C., Schartau P., Hagemeier C., Mushtaq A., Lucas S., et al. Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis. Microbiology 147 (2001) 3295-3302
35. Brooke E.W., Davies S.G., Mulvaney A.W., Pompeo F., Sim E., and Vickers R.J. An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases. Bioorg. Med. Chem. 11 (2003) 1227-1234
36. Upton A., Johnson N., Sandy J., and Sim E. Arylamine N-acetyltransferases-of mice, men and microorganisms. Trends. Pharmacol. Sci. 22 (2001) 140-146
37. Dewsnup D.H., and Wright D.N. In vitro susceptibility of Nocardia asteroides to 25 antimicrobial agents. Antimicrob. Agents Chemother. 25 (1984) 165-167
38. Victor T.C., Warren R., Butt J.L., Jordaan A.M., Felix J.V., Venter A., et al. Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis. J. Med. Microbiol. 46 (1997) 847-857
39. Glupczynski Y., Berhin C., Janssens M., and Wauters G. Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin. Microbiol. Infect. 12 (2006) 905-912
40. Cribb A.E., Nakamura H., Grant D.M., Miller M.A., and Spielberg S.P. Role of polymorphic and monomorphic human arylamine N-acetyltransferases in determining sulfamethoxazole metabolism. Biochem. Pharmacol. 45 (1993) 1277-1282
41. Sandy J., Holton S., Fullam E., Sim E., and Noble M. Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis. Protein Sci. 14 (2005) 775-782
42. Fersht A. Structure and Mechanism in Protein Science. A Guide to Enzyme Catalysis and Protein Folding. 1st edit vol. 1 (1999), W. H. Freeman and Co, New York
43. Cornish-Bowden A. Fundamentals of Enzyme Kinetics (2001), Portland Press, London
44. Kabsch W. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Crystallogr. 26 (1993) 795-800
45. SYBYL. Tripos Inc., St. Louis, USA.
46. Case D., Darden T., Cheatham T., Simmerling C., Wang J., Duke R., et al. AMBER, 9.0 (2006), University of California, San Francisco, CA
47. Dewar M., Zoebisch E., Healy E., and Stewart J. A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 107 (1985) 3902-3909
48. Jakalian A., Jack D.B., and Bayly C.I. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J. Comput. Chem. 23 (2002) 1623-1641
49. Wang W., and Kollman P.A. Computational study of protein specificity: the molecular basis of HIV-1 protease drug resistance. Proc. Natl Acad. Sci. USA 98 (2001) 14937-14942
50. Duan Y., Wu C., Chowdhury S., Lee M.C., Xiong G., Zhang W., et al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 24 (2003) 1999-2012
51. Luo Y., Barbault F., Gourmala C., Zhang Y., Maurel F., Hu Y., and Fan B. Cellular interaction through LewisX cluster: theoretical studies. J. Mol. Model. 14 (2008) 901-910
52. Kollman P.A., Massova I., Reyes C., Kuhn B., Huo S., Chong L., et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc. Chem. Res. 33 (2000) 889-897
53. Luo Y., Gourmala C., Dong D., Barbault F., Fan B., Hu Y., and Zhang Y. First synthesis of two deoxy Lewis(x) pentaosyl glycosphingolipids. Glycoconjugate J. 25 (2008) 335-344